CORRELATION BETWEEN SERUM CD4+CD29+T CELLS AND SERUM HIF-1A, COX-2 LEVELS IN PATIENTS WITH ULCERATIVE COLITIS

被引:1
|
作者
Pan, Xiugang [1 ]
Li, Zhaoyi [2 ]
Wang, Fengyan [3 ]
Yu, Huimin [4 ]
Li, Yingming [5 ]
机构
[1] Weihai Cent Hosp, Endoscopy Ctr, Weihai, Peoples R China
[2] Shandong First Med Univ, Sch Radiol, Tai An, Shandong, Peoples R China
[3] Weihai Cent Hosp, Dept Gastroenterol, Weihai, Peoples R China
[4] Weihai Cent Hosp, Dept Oncol, Weihai, Peoples R China
[5] Weihai Cent Hosp, Dept Pathol, Weihai, Peoples R China
来源
ACTA MEDICA MEDITERRANEA | 2020年 / 36卷 / 04期
关键词
Ulcerative colitis; CD4+CD29+T cells; HIF-1; alpha; COX-2;
D O I
10.19193/0393-6384_2020_4_374
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To study the correlation between serum CD4 + CD29 + T cells and serum hypoxia inducible factor-1 alpha (HIF-1 alpha) and cyclooxygenase-2 (COX-2) levels in patients with ulcerative colitis. Methods: Eighty patients with ulcerative colitis treated in the department of gastroenterology in our hospital from August 2018 to August 2019 were randomly selected as the study group. Based on their condition, patients were divided into two subgroups: the remission group and the active group. Forty healthy people in the physical examination center of our hospital were used as the control group. Serum CD4 + CD29 + T cells, HIF-1 alpha, and COX-2 levels were detected and compared in each group, and correlation between serum CD4 + CD29 + T cells and serum HIF-1 alpha and COX-2 levels in patients with ulcerative colitis was explored. Results: The percentage of CD4 + CD29 + T cells in patients with ulcerative colitis in active stage was much higher than that in healthy people and patients with ulcerative colitis in remission stage, and the difference was statistically significant (P<0.01); patients with active stage of ulcerative colitis. The levels of HIF-1 alpha and COX-2 were significantly higher than those in healthy people and patients with ulcerative colitis in remission stage, and the differences were statistically significant (P<0.01). There was no significant difference in the percentage of CD4 + CD29 + T cells, HIF-1 alpha, and COX-2 levels in healthy people and patients with ulcerative colitis in remission stage (P<0.05). HIF-1 alpha was not expressed or weakly expressed in the intestinal tissue of healthy people and patients with ulcerative colitis in remission phase. HIF-1 alpha appeared obvious expression state in intestinal inflammatory cells, vascular endothelial cells and epithelial cells in patients with ulcerative colitis in active stage; the cytoplasm and nucleus of cells were brownish yellow or brown. COX-2 was not expressed in the intestinal tissue of healthy people and patients with ulcerative colitis in remission stage. COX-2 was significantly expressed in inflammatory cells, vascular endothelial cells and epithelial cells in the intestine of patients with ulcerative colitis in active stage. In the Pearson correlation analysis, CD4 + CD29 + T cells were positively correlated with HIF-1 alpha and COX-2 (r1= 0.512, r2 = 0.439, P<0.05), and HIF-1 alpha was positively correlated with COX-2 (r = 0.691, P = 0.021). Conclusion: The levels of serum CD4 + CD29 + T cells, serum HIF-1 alpha and COX-2 in patients with ulcerative colitis are higher than those in healthy people. CD4 + CD29 + T cells are positively correlated with HIF-1 alpha and COX-2.
引用
收藏
页码:2409 / 2413
页数:5
相关论文
共 50 条
  • [21] Correlation of OX40 ligand on B cells with serum total IgE and IL-4 levels by CD4+ T cells in allergic rhinitis
    Fouladi, S.
    Masjedi, M.
    Hakemi, M. G.
    Ghasemi, R.
    Eskandari, N.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2019, 47 (03) : 234 - 240
  • [22] LRCH1 suppresses migration of CD4+ T cells and refers to disease activity in ulcerative colitis
    Wang, Yibo
    Zhang, Hairong
    He, Heng
    Ai, Kuankuan
    Yu, Wei
    Xiao, Xiao
    Qin, Yufen
    Zhang, Lingming
    Xiong, Huabao
    Zhou, Guangxi
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (05): : 599 - 608
  • [23] CORRELATION BETWEEN SERUM LEVELS OF CD64, CD54, sTREM-1 AND INFLAMMATORY FACTORS AND SENILE BACTERIAL PNEUMONIA
    Zhou, Jianning
    ACTA MEDICA MEDITERRANEA, 2019, 35 (03): : 1219 - 1223
  • [24] Inverse correlation between NKG2D expression on CD8+T cells and the frequency of CD4+CD25+regulatory T cells in patients with esophageal cancer
    Osaki, T.
    Saito, H.
    Fukumoto, Y.
    Yamada, Y.
    Fukuda, K.
    Tatebe, S.
    Tsujitani, S.
    Ikeguchi, M.
    DISEASES OF THE ESOPHAGUS, 2009, 22 (01): : 49 - 54
  • [25] TGF-β1和COX-2对CD4+CD25+调节性T细胞的调控作用
    夏桃林
    吴振权
    杨明
    李辽源
    医学综述, 2010, 16 (22) : 3390 - 3392
  • [26] Quantitative changes of T helper cell 3 and CD4+CD25+T regulator cells in peripheral blood and the serum levels of TGF-β1 of the patients with severe aplastic anemia.
    Shao, Zonghong
    Tu, Meifeng
    Liu, Hong
    He, Guangsheng
    Shi, Jun
    Bai, Jie
    Cao, Yanran
    Wang, Huaquan
    Xing, Limin
    Cui, Zhenzhu
    BLOOD, 2006, 108 (11) : 11B - 11B
  • [27] A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4+T Cells into Th1 Cells
    Dandan Dou
    Yuge Ji
    Junjie Zheng
    Jingxin Li
    Xiaolong Zhu
    Shuhai Tang
    Hongjuan Wang
    Qin Li
    Haiyan Jing
    Digestive Diseases and Sciences, 2022, 67 : 3683 - 3692
  • [28] A vitamin D receptor agonist converts CD4+T cells to Foxp3+regulatory T cells in patients with ulcerative colitis
    Lu, Dong
    Lan, Bin
    Din, Zonren
    Chen, Hang
    Chen, Guoqiang
    ONCOTARGET, 2017, 8 (32) : 53552 - 53562
  • [29] A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4+T Cells into Th1 Cells
    Dou, Dandan
    Ji, Yuge
    Zheng, Junjie
    Li, Jingxin
    Zhu, Xiaolong
    Tang, Shuhai
    Wang, Hongjuan
    Li, Qin
    Jing, Haiyan
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (08) : 3683 - 3692
  • [30] Increased ratio of colonic CD4+CD25hi regulatory T cells in ulcerative colitis patients in exacerbation versus remission of disease.
    Holmén, N
    Lundgren, A
    Rudin, A
    Sjovall, H
    Öhman, L
    GASTROENTEROLOGY, 2005, 128 (04) : A504 - A504